Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M109465200 on December 17, 2001

J. Biol. Chem., Vol. 277, Issue 10, 8395-8405, March 8, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/10/8395    most recent
M109465200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ji, H.-L.
Right arrow Articles by Benos, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ji, H.-L.
Right arrow Articles by Benos, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Up-regulation of Acid-gated Na+ Channels (ASICs) by Cystic Fibrosis Transmembrane Conductance Regulator Co-expression in Xenopus Oocytes*

Hong-Long JiDagger , Biljana JovovDagger , Jian FuDagger §, LaToya R. BishopDagger , Hannah C. MebaneDagger , Catherine M. FullerDagger , Bruce A. Stanton, and Dale J. BenosDagger ||

From the Dagger  Department of Physiology and Biophysics, University of Alabama, Birmingham, Alabama 35294 and  Department of Physiology, Dartmouth Medical School, Hanover, New Hampshire 03755

Received for publication, October 1, 2001, and in revised form, November 19, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cystic fibrosis transmembrane conductance regulator (CFTR) functions as both a chloride channel and an epithelial transport regulator, interacting with Na+ (epithelial sodium channel), Cl-, renal outer medullary potassium channel+, and H2O channels and some exchangers (i.e. Na+/H+) and co-transporters (Na+-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP>, Na+-K+-2Cl-). Acid-sensitive ion channels (ASICs), members of the epithelial sodium channel/degenerin superfamily, were originally cloned from neuronal tissue, and recently localized in epithelia. Because CFTR has been immunocytochemically and functionally identified in rat, murine, and human brain, the regulation of ASICs by CFTR was tested in oocytes. Our observations show that the proton-gated Na+ current formed by the heteromultimeric ASIC1a/2a channel was up-regulated by wild type but not by Delta F508-CFTR. In contrast, the acid-gated Na+ current associated with either the homomultimeric ASIC1a or ASIC2a channel was not influenced by wild type CFTR. The apparent equilibrium dissociation constant for extracellular Na+ for ASIC1a/2a was increased by CFTR, but CFTR had no effect on the gating behavior or acid sensitivity of ASIC1a/2a. CFTR had no effect on the pH activation of ASIC1a/2a. We conclude that wild type CFTR elevates the acid-gated Na+ current of ASIC1a/2a in part by altering the kinetics of extracellular Na+ interaction.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Hyperactivated Na+ absorption through epithelial sodium channel (ENaC)1 is important in the pathophysiology of cystic fibrosis (CF (1-5)). The idea that the cystic fibrosis transmembrane conductance regulator (CFTR) may function as a regulator of ENaC has been tested in systems co-expressing CFTR and ENaC (6-8). Those studies demonstrated that wild type but not mutant CFTR expression functionally down-regulates ENaC, and ENaC stimulates the activity of CFTR (8-10). Also, defective Na+ absorption is restored by CFTR replacement therapy (11). Mutagenesis studies show that the cytoplasmic regulatory domain of CFTR and the cytosolic C termini of beta - and gamma -ENaCs contribute to the functional and physical intermolecular interactions between CFTR and ENaC (8, 10). Because the sulfonylurea receptors, a branch of the family of ATP binding cassette (ABC) transporter proteins, show a high degree of homology with CFTR, Konstas et al. (12) studied the interaction between sulfonylurea receptors and ENaC. They concluded that sulfonylurea receptors inhibit Na+ transport by reducing surface expression of ENaC, but there is no protein-protein interaction at the level of the plasma membrane. Although several mechanisms have been proposed to explain the interaction between CFTR and ENaC, they have not yet been systematically tested (13-16).

A new subfamily of the ENaC/DEG superfamily, the acid-sensing ionic channels (ASICs), has recently been identified (17). Like other family members, ASICs are thought to have a single, large extracellular loop, and two short transmembrane domains with both the C and N termini located intracellularly (17). ASICs are ligand-gated ion channels activated by extracellular acidification and perhaps mechanical stimulation. The biophysical and pharmacological characteristics of ASICs are similar to those of ENaC, albeit with a lower sensitivity to amiloride (Ki ~ 10 µM versus 0.1 µM) and a different cation permeability pattern (17). However, the acid-gated cation current is transiently (seconds) activated and inactivated, whereas ENaC current decreases at extracellular pH 6.4 after a transient increase (18). Likewise, the native amiloride-sensitive Na+ conductance is activated by slightly acidic pHe (5.5 or 6.4) in toad bladder and A6 cells (18, 19). ASIC members, like ENaC, may assemble as a tetramer or as a higher order heteromultimeric channel (20). The biophysical features of heteromultimeric channels constructed with ASIC1a and ASIC2a (ASIC1a/2a) or ASIC2b with ASIC3 (ASIC2b/3) can be distinguished from those built from homomultimeric individual channels (21, 22). ASIC1a (23, 24), ASIC2a (21, 23, 25-28), and ASIC2b (21) show a wide-spread distribution in the brain. ASIC1a, ASIC1b (29), ASIC2b, and ASIC3 (30, 31) have been localized to dorsal root ganglion sensory neurons. However, CFTR expression has not been reported in the peripheral neuronal tissues. Human ASIC3 is distributed in both neuronal tissues and epithelial tissues (32), and a splice variant (hTNaC1) was cloned from human testis (33). The most recently discovered homolog, ASIC4, has been found in the spinal cord, the pituitary gland, and the inner ear (34, 35). The distribution of ASIC members thus extends beyond the central nervous system.

CFTR has been immunocytochemically and electrophysiologically identified in rat brain (36-40), human hypothalamus (41), and a murine neuronal cell line established from the hypothalamus (42). In these same groups of neurons where CFTR is found, ASIC1a and ASIC2a are also expressed (17). The function of neuronal CFTR remains unknown. It is proposed that neuronal CFTR may regulate membrane trafficking processes of cytoplasmic ionic transporters and secretion of neuropeptides (42). Decreased CFTR expression in GT1-7 hypothalamic neurons produced by antisense against CFTR mRNA inhibits gonadotropin-releasing hormone secretion (42). Gonadotropin-releasing hormone has been postulated to be related to the infertility and delayed sexual maturation of CF patients in a developmentally sensitive pattern (42, 43). ASICs may act as pain sensors, mechanical receptors, and/or components of a signal transduction pathway responding to extracellular acidity.

To investigate the possible functional regulation by neuronal CFTR on ASIC1a/2a, the objective of the present study was to use Xenopus oocytes as an expression model to study the effect of human CFTR on the channel activity of ASIC1a/2a. Our results show that CFTR up-regulates proton-gated Na+ currents by altering the kinetics of extracellular Na+ interaction with ASIC1a/2a.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

cRNA Preparation-- Full-length human ASIC1a (BNaC2) and ASIC2a (BNaC1) cDNAs and their "degenerin" mutants were kind gifts of Drs. D. Corey and J. García-Añoveros (Harvard Medical School (23)). DNA samples were in vitro transcribed using either SP6 or T3 mMessage Machine kits (Ambion, TX) as appropriate. The quality and size of the cRNAs were confirmed by denaturing formaldehyde-agarose gel electrophoresis. RNA concentration was estimated by UV spectrophotometry at a wavelength of 260 nm.

Immunofluorescence of Rat Hypothalamus-- Expression of ASIC2a and CFTR in the rat hypothalamus was stained by indirect immunofluorescence. Rats were anesthetized with halothane, perfused transcardially with 60 ml of ice-cold phosphate-buffered saline, and followed by 60 ml of ice-cold 4% paraformaldehyde. This protocol was reviewed and approved by the University of Alabama at Birmingham Institutional Animal Use and Care Committee. The brains were then removed from the skull, post-fixed in the same fixative for 2-4 h on ice, and cryoprotected by overnight immersion in 30% sucrose in phosphate-buffered saline. Tissue samples were embedded in optimal cutting temperature compound (Sakura Finetek, Torrance, CA) medium, then 5-µm frozen sections were obtained. The sections were incubated with the primary antibody solution for 72 h at 4 °C with 5% normal goat serum and 0.1% Triton X-100. Rat brain tissue sections were labeled with one or two of the following antibodies: a 1:50 dilution of polyclonal anti-CFTR antibodies (44); a 1:20 dilution of monoclonal anti-CFTR antibody (45); or a 1:20 dilution of polyclonal anti-ASIC2a antibodies (Alamone, Jerusalem, Israel). The identity of the stained cells as neurons was established using co-staining with a 1:20 dilution of neuron-specific nuclear monoclonal antibodies NeuN (CHEMICO International, Temecula, CA). The samples were rinsed in phosphate-buffered saline and exposed to the secondary antibody solution, goat anti-rabbit-Alexa 594 for ASIC2a and NeuN (1:200, Molecular Probes, Eugene, OR), or goat anti-mouse-Alexa 488 for CFTR (1:200, Molecular Probes) for 2 h at room temperature. Samples were rinsed in phosphate-buffered saline, mounted, and examined using an Olympus 1 × 70 epifluorescence microscope. Nonimmune IgG and the secondary antibodies were used as controls. The distribution of ASIC1a was not examined because of a lack of a suitable antibody.

Oocyte Preparation-- Oocytes were surgically removed from anesthetized adult female Xenopus laevis (Xenopus Express, Beverly Hills, FL) by standard techniques (46). Follicle cells were removed in OR-2 calcium-free medium (82.5 mM NaCl, 2.4 mM KCl, 1.0 MgCl2 mM , 5.0 mM Na-HEPES, pH 7.5) with the addition of collagenase (3 mg/ml). Defollicated oocytes were washed in OR-2 medium to which 50 mM CaCl2 was added and allowed to recover overnight in half-strength Teibovitz medium at 18 °C. Groups of stage VI oocytes were injected with 50 nl of RNase-free H2O or cRNA containing 2.5 ng of CFTR cRNA and 12.5 ng of ASIC cRNA. Two-electrode voltage clamp measurements were made 24-72 h post-injection at room temperature (22-24 °C). This protocol was reviewed and approved by the University of Alabama at Birmingham Institutional Animal Use and Care Committee.

Electrophysiological Recordings-- Whole-cell proton-gated Na+ currents were measured in oocytes expressing ASICs and CFTRs with conventional dual electrode voltage clamps as described previously (46). Oocytes were impaled with two 3 M KCl-filled electrodes, each having resistances of 0.5-1.5 MOmega . The virtual current monitor/bath clamp head stage of the Dagan TEV-200 whole-cell clamp monitors the macroscopic currents flowing through the oocyte and simultaneously maintains the bath at zero potential. This head stage corrects for voltage deviations introduced by current flow through the reference electrode and agar bridge so that oocyte current can be recorded precisely without the series resistance compensation. Two chlorinated Ag-AgCl pellets (1 mm in diameter), each with a resistance below 500 Omega , were used as reference electrodes and were connected to the bath by 3 M KCl, 3% agar bridges (resistance was ~200 Omega ). The control superfusate was ND96 (96 mM NaCl, 1 mM MgCl2, 1.8 mM CaCl2, 2 mM KCl, and 5 mM HEPES, pH 7.5). To prepare ND-96 medium with pH below 6.0, HEPES was replaced with MES. Equimolar concentrations of N-methyl-D-glucamine were used to replace NaCl in those experiments where the [Na+]o was varied. To allow the ASIC channels to recover completely from de-sensitization after bath solution acidification, solutions of acidic pH were applied for a period of 10 s separated by an interval of at least 45 s at pH 7.5. The current-voltage (I-V) relationships were acquired by stepping the holding potential in 20-mV increments from -100 to +100 mV. The effects of bath solution acidification (pH 4.0) on the resting membrane potential were recorded, and acid-gated Na+ entry through ASICs was measured. Data for voltage and current clamps were sampled at the rate of 1 kHz and filtered at 500 kHz. Experimental protocols were controlled by pCLAMP 8.2 software (Axon Instruments, Burlingame, CA), and Na+ currents at -60 mV were digitized and stored on the hard drive of a computer for later analysis.

Data Analysis-- All macroscopic currents presented in this paper are proton-activated Na+ currents. The maximal inward or outward current activated by low pHe was measured and referred to as the transient peak current (Ip, nA). Ip usually occurred within 500~1000 ms after the change in pHe. The relatively stable current was measured 8 s after the application of acidic pHe and is referred to as the sustained current (Is, nA). The inactivation time constant (tau i, ms) was calculated by fitting the time course of current decay subsequent to peak current according to the equation,
f(t)=<LIM><OP>∑</OP><LL>i=1</LL><UL>n</UL></LIM> A<SUB>i</SUB>e<SUP>t/&tgr;<SUB>i</SUB></SUP>+C (Eq. 1)
where A stands for the current amplitude, tau i is the inactivation time constant, C is the basal current recorded at pH 7.5 for each component i, and t is the time period of the recording. The inactivating current (from the peak current to 8 s) was fit to a first order exponential. Determination of tau i is depicted in Fig. 2B.

Computation of the EC50 of the external proton concentration (pH<UP><SUB><IT>e[/i]</IT></SUB><SUP>0.5</SUP></UP>) was performed by fitting both the acid-gated peak current and the sustained currents as a function of external pH with the Hill equation,
I<SUB><UP>Na</UP></SUB>=I<SUB><UP>max</UP></SUB><FR><NU><UP>pH</UP><SUP>n</SUP><SUB>e</SUB></NU><DE><UP>pH</UP><SUP>n</SUP><SUB>e</SUB>+<UP>EC</UP><SUB>50</SUB><SUP>n</SUP></DE></FR> (Eq. 2)
where INa is the proton-gated currents, Imax is the maximal acid-gated current, pHe stands for the extraoocyte pH, EC50 represents the value of pHe, which results in half of the maximal current of the ASIC channel, and n is the Hill coefficient. To further verify the calculation, the Hill coefficient and EC50 were also computed by fitting the normalized acid-gated Na+ currents with the equation,
<FR><NU>I<SUB><UP>max</UP></SUB>I<SUB><UP>Na</UP></SUB></NU><DE>I<UP>max</UP></DE></FR>=<FR><NU>1</NU><DE>1+<FR><NU><UP>EC<SUB>50</SUB></UP></NU><DE>[<UP>H<SUP>+</SUP></UP>]<SUB>e</SUB></DE></FR></DE></FR> (Eq. 3)
where [H+]e is the proton concentration in the bath solution.

To analyze the steady-state kinetics for proton-activated Na+ current as a function of bath solution [Na+], superfusates containing variable concentrations of Na+ (ranging from 0 to 96 mM) were sequentially superfused into the chamber. Km and Imax were calculated by fitting the proton-gated Na+ currents against the concentration of extracellular Na+ with the Michaelis-Menten equation,
I<SUB><UP>Na</UP></SUB>=I<SUB><UP>max</UP></SUB> · <FR><NU>[<UP>Na</UP>]</NU><DE>K<SUB>m</SUB>+[<UP>Na</UP>])</DE></FR> (Eq. 4)
where Km is the concentration required for activating half of the maximal current, Imax and INa are the proton-gated currents, and [Na] represents the extraoocyte concentration of sodium. A nonlinear curve fitting subroutine was applied to fit the data.

All results are presented as the mean ± S.E. Student's t test was used to compare means. A probability level of 0.05 or less was considered significant.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

CFTR Co-localizes with ASIC2a-- ASIC2a and CFTR were detected in rat anterior hypothalamus by indirect immunofluorescence (Fig. 1). Control sections labeled with nonimmune IgG and secondary antibodies did not reveal any staining (not shown). CFTR is expressed in long cellular processes, most likely dendrites (Fig. 1, top panel). ASIC2a is expressed in punctate regions, most likely cell bodies of neurons (Fig. 1B, middle panel). Double-labeling with anti-CFTR and anti-ASIC2a antibodies revealed that CFTR is primarily expressed in a sub-population of neuronal cells expressing ASIC2a (Fig. 1, bottom panel). Some co-localization is also observed in neuronal cellular processes. Similar patterns of co-localization have also been observed in the hippocampus (not shown).


View larger version (79K):
[in this window]
[in a new window]
 
Fig. 1.   Co-localization of ASIC2a and CFTR in rat hypothalamus. All panels represent epifluorescent images taken from sagittal sections of the rat hypothalamus. A, top panel, CFTR was stained using monoclonal anti-CFTR antibodies. CFTR-labeled sub-population of neuronal cells and their processes is shown. B, middle panel, ASIC2a was stained using commercially available polyclonal anti-ASIC2a antibodies. ASIC2a strongly labeled cells bodies in the same region of hypothalamus. C, bottom panel, double staining with anti-CFTR and anti-ASIC2a antibodies overlap in sub-population of neuronal cell bodies and processes.

CFTR Activates Acid-gated Currents-- To avoid any current from endogenous hyperpolarization-activated ion channels, which are activated at membrane potentials more hyperpolarized than -140 mV (47), the exogenous acid-gated Na+ currents associated with ASICs were obtained while oocytes were clamped at -60 mV. Reduction of pHe (4.0) had no effect on INa in water-injected oocytes (Figs. 2 and 3).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   Activation of ASICs by external acidic pH. A, representative acid-gated Na+ current at holding potential of -60 mV in an oocyte. The solid line above the trace shows the period of acidic pH application (10 s). B, representative inward Na+ current in an oocyte expressing ASIC1a/2a. The distance indicated by the left pair of arrows is the time to peak current (see "Experimental Procedures"). The dotted line overlapped on the trace was produced by fitting the component of the de-sensitization current with a first order exponential decay function to compute the inactivation time constant (tau i). C, representative acid-induced Na+ current in an oocyte co-expressing ASIC1a/2a and CFTR. D, representative acid-gated Na+ current in an oocyte expressing ASIC1a/2a and Delta F508-CFTR. These whole cell current traces were recorded from oocytes isolated from the same frog and at the same time point (48 h) after cRNA injection. These experiments were repeated more than 5 times. The scale bars for the x axis (2 s) and y axis (5 µA) are applied to all four panels.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3.   Up-regulation of acid-gated conductance associated with the heteromultimeric ASIC1a/2a channel by CFTR co-expression. A, I-V relationship of peak current. The proton-gated transient Na+ currents (I<UP><SUB><IT>p</IT></SUB><SUP>Na</SUP></UP>) for the heteromultimeric ASIC1a/2a channel alone (circles) and co-expressed with CFTR (squares) were evoked at membrane potentials (Vm) ranging from -100 mV to +100 mV. The macroscopic conductances are linear for both groups with reversal potentials of about +30 mV. B, corresponding I-V curve of sustained current (I<UP><SUB><IT>s</IT></SUB><SUP>Na</SUP></UP>). Reversal potentials were ~7 mV for ASIC1a/2a and 10 mV for CFTR and ASIC1a/2a as indicated by the arrows. C, average macroscopic currents of the transient Na+ currents (I<UP><SUB><IT>p</IT></SUB><SUP>Na</SUP></UP>) in water-injected oocytes (H2O) with (ASIC1a/2a + CFTR) and without CFTR co-expression (ASIC1a/2a). D, corresponding whole-cell sustained Na+ currents (I<UP><SUB><IT>s</IT></SUB><SUP>Na</SUP></UP>) evoked by pH 4.0 at a holding potential of -60 mV for H2O, ASIC1a/2a, and ASIC1a/2a + CFTR. n stands for the number of cells.

In oocytes expressing ASIC1a/2a, a reduction in pHe (4.0) transiently activated an inward Na+ current. The current peaked (Ip) and then decayed exponentially to a value close to basal (unstimulated) values (Fig. 2B). The transiently activated Na+ current associated with ASIC1a/2a generally reached its peak in 500 ms or less (Ip) after switching the pHe to 4.0 from 7.5. However, the acid-gated Na+ current took 1000 ms or more to become sustained (Is). The de-sensitized current fits to a first order exponential decay. The acid-gated sustained Na+ current (Is) was measured 8 s after acidic pHe application. The characteristics of acid-gated Na+ currents described here are consistent with those demonstrated by a number of other investigators (17, 20-22, 27, 48, 49). CFTR increased the acid-activated Na+ currents (Ip and Is); however, Delta F508-CFTR had no effect on Ip and Is (Fig. 2, C and D).

The current-voltage (I-V) relationships of both Ip and Is for the heteromultimeric ASIC1a/2a channel displayed a linear conductance (Fig. 3, A and B). CFTR co-expression increased the slope conductance of the I-V curves for Ip, leaving the reversal potential (~30 mV) unchanged (Fig. 3A). CFTR co-expression also increased the slope conductance of the I-V curve for Is (Fig. 3B). The reversal potential for Is was also unchanged by CFTR (Fig. 3B). Ip of ASIC1a/2a was -6772 ± 985 nA (n = 20) at a holding potential of -60 mV (Fig. 3C), significantly greater than the current in uninjected oocytes (-14 ± 17 nA, p < 0.001). ASIC1a/2a-associated Ip was up-regulated in oocytes co-expressing CFTR (-15,554 ± 2,880 nA, p < 0.01) compared with oocytes expressing ASIC1a/2a alone. Is in the presence of CFTR also markedly increased to -2217 ± 506 (n = 19) from -624 ± 124 nA (n = 20; p < 0.01, Fig. 3D). In contrast to the up-regulatory effect of CFTR on ASIC1a/2a, Delta F508-CFTR co-expression did not show a significant alteration in Ip or Is (Fig. 2C).

CFTR Co-expression with either ASIC1a or ASIC2a-- Our previous studies demonstrated that beta - and gamma -ENaCs were involved in the cross-talk between CFTR and ENaC (8). In an attempt to identify which isoform of the heteromultimeric ASIC1a/2a channel was involved in the intermolecular interaction with CFTR, we co-expressed CFTR with either ASIC1a or ASIC2a in oocytes. As shown in Fig. 4, CFTR did not increase Ip or Is produced by ASIC1a clone or by ASIC2a clone. However, the time to peak current was 1851 ± 414 ms (n = 9), and tau i was 3613 ± 17 (n = 9) for ASIC1a, slower than those of ASIC2a or ASIC1a/2a.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 4.   CFTR did not activate ASIC1a or ASIC2a channels. A, representative acid-activated Na+ current (pH 4.0) traces in oocytes, from the left to the right, expressing ASIC1a alone, ASIC1a co-expressed with CFTR, ASIC2a alone, co-expressed with CFTR. The holding potential is -60 mV. B, transient macroscopic Na+ currents (I<UP><SUB><IT>p</IT></SUB><SUP>Na</SUP></UP>). C, macroscopic sustained currents (I<UP><SUB><IT>s</IT></SUB><SUP>Na</SUP></UP>).

To examine the effect of CFTR activation on ASICs, we first tested the effect of a cAMP-elevating mixture on ASIC1a/2a. After application of this cAMP-elevating mixture, the normalized Ip decreased to 92 ± 5.1% (n = 5, p > 0.05) of its value before mixture application. In oocytes co-expressing ASIC1a/2a with CFTR, ASIC1a/2a Ip was increased by 220 ± 31%. Application of the cAMP-elevating mixture produced a saturation of the CFTR current and did not significantly influence the proton-gated ASIC1a/2a current (-1665 ± 974 nA without mixture versus -1502 ± 842 nA with mixture, n = 6, p > 0.05).

CFTR Co-expression on pH Sensitivity of ASIC1a/2a-- To determine whether CFTR co-expression modified the protonation of ASIC1a/2a channels, solutions of different external pH were applied to calculate the pHe required for half-activation of the maximal conductance (EC50). Current transients for ASIC1a/2a, in the presence and absence of CFTR, were measured at different solution pH values (Fig. 5A). CFTR had no effect on the EC50 for acid activation of ASIC1a/2a (Fig. 5B). The Hill coefficient was 20.2 ± 3.7 and 22.2 ± 3.7 for ASIC1a/2a alone and ASIC1a/2a + CFTR, respectively, indicating that protonation of multiple sites is required for activating ASIC1a/2a. To verify the above findings, we applied the modified Hill function to the same data (Fig. 5C). The computed apparent bath pH values at the midpoint of the maximal Na+ current were 5.87, 5.95, and 5.99 in oocytes expressing ASIC1a/2a alone, ASIC1a/2a with CFTR, and ASIC1a/2a with Delta F508-CFTR, respectively (n = 9). The same computation was also applied to the sustained Na+ currents, and nearly identical EC50 values as those for the peak currents were computed (data not shown). Thus, there was no difference in ASIC1a/2a sensitivity to external pH in the presence or absence of CFTR (p > 0.05).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 5.   Extracellular proton concentration dependence of Na+ currents. A, proton-induced Na+ currents in oocytes expressing ASIC1a/2a or co-expressing ASIC1a/2a + CFTR. B, pHe-dependent activation. The absolute amplitude of proton-stimulated transient Na+ currents (I<UP><SUB><IT>p</IT></SUB><SUP>Na</SUP></UP>) of ASIC1a/2a (squares), ASIC1a/2a + CFTR (circles), and ASIC1a/2a + Delta F508-CFTR (triangles) were plotted as a function of the external pH from 4.0 to 7.5. The connected lines were created by fitting data points with the Hill equation (see "Experimental Procedures"). C, an alternative method to calculate EC50 of pHe by fitting normalized acid-gated Na+ currents (I/Imax) with the modified Hill equation, plotted against pHe. Holding potential = -60 mV.

CFTR Co-expression on Gating Behavior of ASIC1a/2a-- A further question concerns the influence of CFTR on the kinetics of the ASIC1a/2a channel. To address this issue, the time to peak current and the inactivation time constants of ASIC1a/2a as functions of holding potential and bath solution pH were examined. Fig. 6A demonstrates that there is no difference in the time to peak current as a function of holding potential from -100 mV to +100 mV in the presence or absence of CFTR. Although the average time to peak current of ASIC1a/2a was decreased from 408 ± 34 to 364 ± 17 ms by CFTR (between -60 mV and +100 mV), this difference was not significant (p > 0.05). The summarized results for the inactivation time constants are depicted in Fig. 6B. No significant change at any applied voltage was observed.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of CFTR co-expression on gating behavior of the heteromultimeric ASIC1a/2a channel. A, times to peak current as a function of membrane potential (Vm). The values of the time to peak current at each potential in oocytes expressing ASIC1a/2a (squares) and co-expressed with CFTR (circles) are plotted. Numbers in parentheses are the number of oocytes. B, tau i of ASIC1a/2a channel in the presence (circles) or absence of CFTR (squares). C, kinetics of activation behavior of ASIC1a/2a channel stimulated as a function of pH (6.1-4.0). D, rates of de-sensitization. The values of tau i for ASIC1a/2a (squares) and ASIC1a/2a + CFTR (circles).

The absence of acid-gated Na+ currents in oocytes at pHe 7.5 made it impossible to measure both the time to Ip and inactivation time constant. Therefore, the time to peak currents from the most acidic pHe of 4.0 to the least acidic pHe of 6.1 were plotted in Fig. 6C (n = 6). At pHe 4.0, the time to peak current was 319 ± 22 and 308 ± 24 ms for ASIC1a/2a and ASIC1a/2a co-expressed with CFTR, respectively. The time to peak current was not changed significantly by CFTR co-expression at any pHe (p > 0.05). The inactivation time constant of the ASIC1a/2a channel exhibited a minimal pHe dependence and was unchanged in the presence of CFTR (Fig. 6D).

It appears that in oocytes co-expressing ASIC1a/2a and CFTR, tau i was pHe-dependent and that this was not the case for the heteromultimeric ASIC1a/2a channels expressed in the absence of CFTR (whereas the inactivation time constant was uninfluenced by CFTR co-expression). The inactivation time constants were 938 ± 161 and 1222 ± 86 ms for ASIC1a/2a and co-expressed with CFTR, respectively, at pHe 4.0 (p > 0.05).

Kinetics of Extracellular Sodium Interaction with Heteromultimeric Channel-- The homomultimeric ASIC1a and ASIC2a channels and the heteromultimeric ASIC1a/2a channel are permeant to Na+, Li+, and Ca2+ (17, 22, 51). The heteromultimeric ASIC1a/2a channel has distinctly different biophysical and pharmacological features from homomultimeric ASIC1a and ASIC2a channels (22). Thus, we tested the hypothesis that the kinetics of extracellular sodium interaction with the ASIC1a/2a channel could be affected by CFTR co-expression. This was examined by sampling acid-gated Na+ currents from oocytes expressing ASIC1a/2a plus and minus CFTR at various extracellular Na+ concentrations. As shown in Fig. 7, the peak of the acid-activated transient Na+ current (Ip) and the sustained Na+ current (Is) levels are dependent on the external [Na+]. The estimated Km obtained by fitting the peak current (Fig. 7A) with the Michealis-Menten function was 105 ± 13 and 166 ± 19 mM for ASIC1a/2a and ASIC1a/2a + CFTR, respectively. These values are statistically different (p < 0.05). Similarly, the Km values calculated from the sustained Na+ currents were 102 ± 13 and 164 ± 8 mM for ASIC1a/2a and ASIC1a/2a + CFTR, respectively, again significantly different from one another (Fig. 7B, p < 0.05). The time to peak and tau i were not affected by CFTR at various external [Na+] (Fig. 7C).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   CFTR co-expression on kinetics of extracellular Na+ interaction with ASIC1a/2a channel. The holding potential is -60 mV. Extracellular proton concentration is 10-4 M. A, normalized acid-gated transient Na+ currents evoked in the presence of a series of external Na+ concentrations ranging from 0 to 96 mM in oocytes expressing heteromultimeric ASIC1a/2a channel (squares) and co-expressed with CFTR (circles). The normalized Ip was calculated as I<UP><SUB><IT>p</IT></SUB><SUP>norm</SUP></UP> = Ip(0) - Ip(Na), where Ip(0) is the peak current in the absence of sodium, and Ip(Na) is the peak current sampled in the presence of different extraoocyte sodium. The data points are connected with fitting curves drawn by the Michealis-Menten equation (see "Experimental Procedures" for details). B, the normalized sustained Na+ currents obtained with a range of extraoocyte Na+. Calculation of normalized Is and representation of the symbols are identical to panel A. C, gating kinetics of ASIC1a/2a channel as a function of external sodium ([Na+]e). Both times to peak (circles) and inactivation time constants (squares) for ASIC1a/2a and ASIC1a/2a + CFTR (inverted triangles for time to peak and up-triangles for tau i) are presented in panel C.

Intermolecular Cross-talk Requires Normal Structure-- To address the issue of a possible intracellular sodium dependence of the regulation of ASICs by CFTR, we co-expressed CFTR with a gain-of-function mutant of ASIC2a, namely, G430F. As shown in Fig. 8, expression of G430F-ASIC2a alone exhibited a constitutively activated inward Na+ current at pHe 7.5. Application of acidic pHe (4.0) unmasked a novel additional acid-sensitive Na+ conductance in 6 of 7 oocytes expressing G430F-ASIC2a. The acid-sensitive Na+ current associated with G430F-ASIC2a took up to 8 s to reach its maximal activity and displayed no tendency to inactivate over the observation period (10 s). The influence of CFTR on both the constitutively activated basal Na+ current and the acid-sensitive component (Delta INa) are summarized in Fig. 8, C and D. In oocytes expressing G430F-ASIC2a alone, the basal current (at a holding potential of -60 mV and pHe of 7.5) was -7490 ± 1018 nA (n = 14). CFTR co-expression had no significant effect on this current (mean, -9643 ± 1050 nA, n = 11; p > 0.05). Likewise, CFTR had no effect on the acid-sensitive component of G430F-ASIC2a (-3825 ± 648 nA versus -3541 ± 2158 nA, +CFTR; n = 6). Time to peak of the acid-gated current (for those without peak current, it was calculated as time to stable) increased slightly to 6059 ± 1078 ms from 5278 ± 1169 ms (p > 0.05).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 8.   Co-expression of CFTR with the gain-of-function mutant of ASIC1a, G430F. A, constitutively activated Na+ current at neutral pH (pHe 7.5), proton-activated Na+ current (pHe 4.0), and the net proton-sensitive Na+ conductance (Delta INa) in a single oocyte expressing G430F-ASIC1a. Delta INa is the difference of proton-induced Na+ current at pHe 7.5 and that at pHe 4.0. The scale for the abscissa is 2 s and for the ordinate is 2 µA. These currents were recorded by switching the holding potential from 0 to -60 mV while pHe 4.0 was being superfused. B, whole-cell proton-gated Na+ currents in an oocyte co-expressing ASIC1a/2a with CFTR. The experimental protocol, Delta INa measurement, and symbols are same as in panel A. C, constitutively activated Na+ currents. Basal currents (I<UP><SUB>basal</SUB><SUP>Na</SUP></UP>) with (G430F + CFTR) or without (G430F) at neutral pHe. D, proton-sensitive currents (Delta I<UP><SUB><IT>p</IT></SUB><SUP>Na</SUP></UP>). Delta I<UP><SUB><IT>p</IT></SUB><SUP>Na</SUP></UP> was calculated based on the values of Delta INa.

Depolarization of Membrane Potential Induced by Acidic pHe-- If CFTR co-expression increased the rate of positive charge flowing through the heteromultimeric ASIC1a/2a channel, the membrane potential should also be regulated by acidic pHe. This idea was tested in the current clamp mode using the same protocol for acidic pHe application. The average resting membrane potential of uninjected oocytes at pHe 7.5 was -43 ± 5 mV (n = 10, 3 frogs) and -35 ± 2 mV (n = 57, 11 frogs) for ASIC1a/2a-injected oocytes and -42 ± 2 mV (n = 38, 6 frogs, Fig. 9) for ASIC1a/2a + CFTR-injected oocytes. As shown in Fig. 9C, the net change in the maximal depolarized membrane potential (Delta Em) at pHe 4.0 in oocytes co-expressing ASIC1a/2a with CFTR was 39 ± 3 mV (n = 6), significantly greater (p < 0.05) than in oocytes expressing only ASIC1a/2a (24 ± 1 mV, n = 6). The decay rate (2 s) of the membrane potential, calculated by fitting with a first order exponential, paralleled the tau i of the ASIC1a/2a-associated, acid-gated Na+ currents (1.5 s). These observations indicate that there was a coupling between the proton-gated Na+ current and the proton-induced depolarization of the membrane potential, suggesting that the depolarization of membrane potential resulted from the entry of positive charge carried by Na+ through ASICs.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 9.   Depolarization of membrane potential (Em) caused by extraoocyte acidification. Current clamp technique was applied to digitize changes in the resting membrane potential resulting from extracellular acidity (pHe 4.0). A, H2O-injected oocyte. The line under the potential trace (E<UP><SUB><IT>m</IT></SUB><SUP>H<SUB>2</SUB>O</SUP></UP>) indicates the application of pHe 4.0. B, representative potential trace (E<UP><SUB><IT>m</IT></SUB><SUP>ASICs</SUP></UP>) from an oocyte expressing ASIC1a/2a (ASIC-associated). The difference of the potential trace (Delta Em = E<UP><SUB><IT>m</IT></SUB><SUP>H<SUB>2</SUB>O</SUP></UP> - E<UP><SUB><IT>m</IT></SUB><SUP>ASICs</SUP></UP>) of ASIC1a/2a (Total) and the background noise recorded in H2O-injected oocyte (A). C, potential trace (E<UP><SUB><IT>m</IT></SUB><SUP>ASICF</SUP></UP>) recorded in an oocyte co-expressing ASIC1a/2a with CFTR and the net change (Delta Em = E<UP><SUB><IT>m</IT></SUB><SUP>H<SUB>2</SUB>O</SUP></UP> - E<UP><SUB><IT>m</IT></SUB><SUP>ASICF</SUP></UP>) in membrane potential caused by acidity. D, average membrane potentials. Maximal depolarization of Em by acidic pH 4.0 in oocytes injected with H2O (square), expressing ASIC1a/2a (circles) and co-expressing ASIC1a/2a with CFTR (triangles) are shown. The rate of decay of Em depolarization for oocyte expressing ASIC1a/2a is 2104 ± 14 ms and 2177 ± 15 ms for ASIC1a/2a + CFTR.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The purpose of the present study was to examine the hypothesis that CFTR may interact with other members of the ENaC/DEG superfamily, the ASICs. We co-expressed CFTR with ASIC1a and/or ASIC2a in Xenopus oocytes, and the proton-gated Na+ currents were evaluated with the conventional two-electrode voltage clamp technique. Our results demonstrated that steady-state CFTR up-regulates ASIC1a/2a, which was opposite to the effect of CFTR on rat ENaC (8). Taken together, our studies strongly suggest that the cross-talk between CFTR and these ENaC/DEG family members is very specific.

Our immunolocalization results revealed that both CFTR and ASIC2a channel proteins are co-expressed in hypothalamic neurons. These observations are completely in agreement with previous studies demonstrating that mRNA for ASIC2a and CFTR are present in hypothalamus (17, 37, 38). Although we did not immunolocalize CFTR and ASIC1a in the hypothalamus due to the lack of antibodies against ASIC1a, ASIC1a and ASIC2a are co-expressed in hypothalamus (for review, see Ref. 17).

CFTR co-expression does not influence the ionic selectivity of the ASIC1a/2a channel (Fig. 3). The reversal potentials (+30 mV) measured in the presence or absence of CFTR co-expression were similar. The measured reversal potentials are in agreement with the prediction of the Goldman-Hodgkin-Katz equation for a highly Na+-permeable cation channel (PNa:PK = 8.8).

Based on the assumption of a physical protein-protein interactions between CFTR and ASIC1a/2a, we tried to identify the ASIC subunit involved in the functional cross-talk of CFTR and ASIC1a/2a. Our results demonstrated that neither the homomultimeric ASIC1a channels nor the homomultimeric ASIC2a channels functionally interact with CFTR.

The opening of acid-gated channels has been proposed to be a consequence of protonation of the channel protein. In the case of ASIC channels, possible multiple protonation domains would be histidine residues located in the extracellular loops. CFTR may alter this process within the ASIC1a/2a channel by pHe. However, our study does not support this idea. No changes were observed in the pHe activation of ASIC1a/2a with CFTR co-expression (Fig. 6, B and C). Furthermore, CFTR co-expression did not regulate the kinetics of the heteromultimeric ASIC1a/2a channel. Apart from the activation rate, which was regulated in a pHe-dependent manner, the inactivation time constant and the time to peak current were not voltage-dependent, pHe-dependent, or dependent on extracellular sodium (Figs. 6 and 7C). CFTR co-expression, therefore, failed to modify the kinetics of protonation of the heteromultimeric ASIC1a/2a channel.

Although CFTR co-expression did not alter the protonation of ASICs, analysis of the kinetics of external Na+ interaction with the heteromultimeric ASIC1a/2a channel revealed a decrease in Na+ concentration required for activating half of the maximal current (Fig. 7). The currents did not saturate at Na+ concentrations between 0 and 100 mM. We did not measure currents at higher Na+ concentrations because the increase in solution osmolarity will change cell volume, which is likely to activate ASICs, which are sensitive to mechanical stimuli (17). The reason why CFTR increased Na+ interaction with the ASIC1a/2a channel is unknown. CFTR may increase open probability and ASIC expression.

ENaC expression in oocytes leads to an increased cytoplasmic sodium concentration accompanied by a depolarized membrane potential due to constitutive channel activity. We hypothesized that the crucial determinant to the contrasting effects of CFTR on ENaCs and on ASICs could be the resultant changes in membrane potential and cytosolic salt concentration. However, the noninteraction of G430F-ASIC2a, and CFTR ruled out this possibility (Fig. 8). These results also suggested, because the active Na+ transport pathway (Na+/K+-ATPase) could not keep pace with passive Na+ leak (Na+ channel, Na+/H+ antiporter, etc.), leading to accumulation of cytosolic Na+ and depolarization of membrane potential possibly accompanied by acidosis, CFTR would not up-regulate ASICs to protect neuronal function. Little is known about the mechanism of the gating behavior of the modified channel.

Recently, Nagel et al. (52) suggested that CFTR inhibition of ENaC was nonspecific. They argue that the apparent interaction results from electrical artifacts produced by a variable access resistance (because of overexpression of CFTR) and an uncompensated electrode resistance. Large changes in membrane resistance caused by CFTR and ASIC expression did not occur in our experiments because the membrane resistance of injected oocytes was close to that of uninjected oocytes in the absence of acidic pHe (~200 Omega ). Thus, the whole cell currents measured in our experiments were much less than the minimum 50 µA/oocyte Nagel et al. (52) calculated that would make voltage clamping problematic. Moreover, the series resistance of the reference electrode, the agar bridges, and bath solution totaled less than 1 kOmega , again less than the 20 kOmega assumed by Nagel et al. (52). Thus, the total series resistance was much less (<4%) than that of the membrane and could therefore not introduce a significant error in voltage measurements. Even assuming that overexpression of CFTR resulted in a change in the access resistance and, thus, produced a significant voltage drop in the bath, it cannot account for the opposite effects of CFTR on ENaCs and ASICs. Therefore, the interaction between CFTR and ENaC/DEG is specific and not due to an artifactual error resulting from an uncompensated series and membrane resistance.

Divalent cations such as Ca2+ and Mg2+ can modulate both ENaC and ASIC activity (17, 29, 49, 53-55). Recently, de Weille and Bassilana (49) showed that external Ca2+ regulated ASIC1a and ASIC2a differently. Furthermore, intracellular Ca2+ only affected ASIC1a. CFTR significantly up-regulates ASICs at a pHe more acidic than 5.5 (Fig. 5B) in contrast to the effects of Ca2+ on ASICs, which is only evident at pHe 7.0 (55). Therefore, the up-regulation of ASICs by CFTR is unlikely due to an increase in cytoplasmic Ca2+ because the effects of cytoplasmic Ca2+ and the regulation of CFTR on the homomultimeric ASIC1a and ASIC2a channels and the heteromultimeric ASIC1a/2a channel are not the same (49).

Even in the case of CFTR regulation of ENaC, diverse observations have been documented in epithelial tissues. The epithelial Na+ channel located in the apical membrane is activated in airway, lung, intestinal, renal epithelia, and in heterologous expression systems (for review, see Refs. 13-16). In contrast, ENaC function depends critically on the state of CFTR in a purely salt-absorbing epithelium, and ENaC cannot be activated in cystic fibrosis sweat gland ducts where CFTR is defective or absent (56). Moreover, the effect of ENaC overexpression on CFTR in the Xenopus oocytes (8, 10) is also different from that observed in mouse endometrial epithelium (57). One explanation for these diverse observations between CFTR and ENaC is that it is due to variant forms of ENaC and CFTR. Alternatively, different accessory components that operate in different cellular systems may underlie these differential effects (56). But the puzzle is still unresolved. Although ASICs are members of the ENaC/DEG family, there are differences in the biophysical and pharmacological characteristics between ENaC and ASIC, including their molecular sequence, cation selectivity, the unitary conductance, gating behavior, sensitivity to amiloride, etc. Furthermore, their responses to regulators or modulators (for example, protons, Ca2+, Mg2+, Na+, neuropeptides, monocarboxylic acids, inflammation, global ischemia, etc.) are different, even opposite (for review, see Refs. 17 and 58). The possibility that the diverse function and regulation between ASICs and ENaC may also contribute to their different interactions with CFTR has not been tested.

Our observations that wild type but not Delta F508-CFTR up-regulated the ASIC1a/2a channel augment the idea that CFTR, functioning as a regulator of a plethora of plasma membrane transporters, may also interact with neuronal membrane proteins. In the central nervous system (CNS), the function of ASICs is still hypothetical. The primary function of ASICs in the central nervous system may be to detect pH drops in brain tissue produced by release of neurotransmitters under physiological conditions participating in the regulation of synaptic activity and in pathophysiological conditions, such as cerebral ischemia, seizure, epilepsy, and trauma, where a reduction of tissue pH occurs. Up-regulation of ASICs by CFTR implies that in cystic fibrosis, the relative attenuation of ASICs in brain is less sensitive to pH changes in the absence of normal CFTR. In addition, CFTR itself regulates proton transmembrane transport and, therefore, modulates synaptic activity (13, 16). Because ASICs may also respond to other stimuli, including Phe-Met-Arg-Phe-amide and other neuromodulatory substances (32), up-regulation of ASICs by CFTR can contribute to the motor and sensory neuronal function, for example, modulation of nociceptive synaptic transmission (i.e. pain, a most common symptom of cystic fibrosis) by altering central sensitization (59). ASICs may function as one component of oxygen sensors in combination with K+,Cl- channels in O2-sensing and acid-sensing neurons based on the hypothesis that the response to oxygen requires multiple sensors and they work together to shape the overall sensory response of brain neurons over a wide range of arterial oxygen tensions (50). Thus, the interactions of CFTR and ASICs indicate that brain neuropathophysiology in cystic fibrosis patients may be related to a depression of ASICs function in the presence and absence of extracellular acidosis.

Our observations demonstrate that activity of the heteromultimeric ASIC1a/2a channel is up-regulated in the presence of CFTR when co-expressed in Xenopus oocytes at least in part by modifying the interaction with extraoocyte sodium. The physiological relevance in the context of native tissues remains to be explored.

    ACKNOWLEDGEMENTS

We thank Eddie Walthall and Drs. Eric J. Sorscher and Kevin K. Kirk (University of Alabama at Birmingham Cystic Fibrosis Research Center) for technical support and helpful comments.

    FOOTNOTES

* This study was supported by National Institutes of Health Grants DK53468, DK56095, and DK34533 and the Cystic Fibrosis Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Dept. of Pharmacology, University of Washington, Seattle, WA 98195.

|| To whom correspondence should be addressed: Dept. of Physiology and Biophysics, The University of Alabama at Birmingham, 1918 University Blvd., MCLM 704, Birmingham, AL 35294-0005. Tel.: 205-934-6220; Fax: 205-934-2377; E-mail: benos@physiology.uab.edu.

Published, JBC Papers in Press, December 17, 2001, DOI 10.1074/jbc.M109465200

    ABBREVIATIONS

The abbreviations used are: ENaC, epithelial sodium channel; CF, cystic fibrosis; CFTR, CF transmembrane conductance regulator; Omega , ohm; ASIC, acid-sensitive ion channel; MES, 4-morpholineethanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Boucher, R. C., Cotton, C. U., Gatzy, J. T., Knowles, M. R., and Yankaskas, J. R. (1988) J. Physiol. 405, 77-103[Abstract/Free Full Text]
2. Knowles, M. R., Gatzy, J. T., and Boucher, R. C. (1981) N. Engl. J. Med. 341, 156-162[Abstract/Free Full Text]
3. Mall, M., Bleich, M., Greger, R., Schreiber, R., and Kunzelmann, K. (1998a) J. Clin. Invest. 102, 15-21[Medline] [Order article via Infotrieve]
4. Mall, M., Bleich, M., Greger, R., Schürlein, M., Kühr, J., Seydewitz, H. H., Brandis, M., and Kunzelmann, K. (1998b) Am. J. Physiol. 275, G1274-G1281[Abstract/Free Full Text]
5. Mall, M., Bleich, M., Kuehr, J., Brandis, M., Greger, R., and Kunzelmann, K. (1999) Am. J. Physiol. 277, G709-G816[Abstract/Free Full Text]
6. Stutts, M. J., Canessa, C. M., Olsen, J. C., Hamrick, M., Cohn, J. A., Rossier, B. C., and Boucher, R. C. (1995) Science 269, 847-850[Abstract/Free Full Text]
7. Tabcharani, J. A., Rommens, J. M., Hou, Y.-X., Chang, X.-B., Tsui, L. C., Riordan, J. R., and Hanrahan, J. W. (1993) Nature 366, 79-82[CrossRef][Medline] [Order article via Infotrieve]
8. Ji, H.-L., Chalfant, M. L., Jovov, B., Lockhart, J. P., Parker, S. B., Fuller, C. M., Stanton, B. A., and Benos, D. J. (2000) J. Biol. Chem. 275, 27947-27956[Abstract/Free Full Text]
9. Mall, M., Hipper, A., Greger, R., and Kunzelmann, K. (1996) FEBS Lett. 381, 47-52[CrossRef][Medline] [Order article via Infotrieve]
10. Chabot, H., Vives, M. F., Dagenais, A., Grygorczyk, C., Berthiaume, Y., and Grygorczyk, R. (1999) J. Membr. Biol. 169, 175-188[CrossRef][Medline] [Order article via Infotrieve]
11. Johnson, L. G., Boyles, S. E., Wilson, J., and Boucher, R. C. (1995) J. Clin. Invest. 95, 1377-1382
12. Konstas, A. A., Bielfeld-Ackermann, A., and Korbmacher, C. (2001) Pfluegers Arch. Eur. J. Physiol. 442, 752-761[CrossRef][Medline] [Order article via Infotrieve]
13. Kunzelmann, K., Schreiber, R., Nitschke, R., and Mall, M. (2000) Pfluegers Arch. 440, 193-201[Medline] [Order article via Infotrieve]
14. Kunzelmann, K. (2001) News Physiol. Sci. 16, 167-170[Abstract/Free Full Text]
15. Kunzelmann, K., Schreiber, R., and Boucherot, A. (2001) Kidney Int. 60, 455-461[CrossRef][Medline] [Order article via Infotrieve]
16. Schwiebert, E. M., Benos, D. J., Egan, M. E., Stutts, M. J., and Guggino, W. B. (1999) Physiol. Rev. 79, S145-S166
17. Waldmann, R., Champigny, G., Lingueglia, E., de Weille, J. R., Heurteaux, C., and Lazdunski, M. (1999) Ann. N. Y. Acad. Sci. 868, 67-76[CrossRef][Medline] [Order article via Infotrieve]
18. Awayda, M. D., Boudreaux, M. J., Reger, R. L., and Hamm, L. L. (2000) Am. J. Physiol. Cell Physiol. 279, 1896-1905
19. Leaf, A., Keller, A., and Dempsey, F. F. (1964) Am. J. Physiol. 207, 547-552
20. Coscoy, S., Lingueglia, E., Lazdunski, M., and Barbry, P. (1998) J. Biol. Chem. 273, 8317-8322[Abstract/Free Full Text]
21. Lingueglia, E., de Weille, J. R., Bassilana, F., Heurteaux, C., Sakai, H., Waldmann, R., and Lazdunski, M. (1997) J. Biol. Chem. 272, 29778-29783[Abstract/Free Full Text]
22. Bassilana, F., Champigny, G., Waldmann, R., de Weille, J. R., Heurteaux, C., and Lazdunski, M. (1997) J. Biol. Chem. 272, 28819-28822[Abstract/Free Full Text]
23. García-Añoveros, J., Derfler, B., Neville-Golden, J., Hyman, B. T., and Corey, D. P. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1459-1464[Abstract/Free Full Text]
24. Waldmann, R., Champigny, G., Bassilana, F., Heurteaux, C., and Lazdunski, M. (1997) Nature 386, 173-177[CrossRef][Medline] [Order article via Infotrieve]
25. Price, M. P., Snyder, P. M., and Welsh, M. J. (1996) J. Biol. Chem. 271, 7879-7882[Abstract/Free Full Text]
26. Waldmann, R., Champigny, G., Voilley, N., Lauritzen, I., and Lazdunski, M. (1996) J. Biol. Chem. 271, 10433-10436[Abstract/Free Full Text]
27. Champigny, G., Voilley, N., Waldmann, R., and Lazdunski, M. (1998) J. Biol. Chem. 273, 15418-15422[Abstract/Free Full Text]
28. Ugawa, S., Minami, Y., Guo, W., Saishin, Y., Takatsuji, K., Yamamoto, T., Tohyama, M., and Shimada, S. (1998) Nature 395, 555-556[CrossRef][Medline] [Order article via Infotrieve]
29. Chen, C. C., England, S., Akopian, A. N., and Wood, J. N. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 10240-10245[Abstract/Free Full Text]
30. de Weille, J. R., Bassilana, F., Lazdunski, M., and Waldmann, R. (1998) FEBS Lett. 433, 257-260[CrossRef][Medline] [Order article via Infotrieve]
31. Waldmann, R., Bassilana, F., de Weille, J., Champigny, G., Heurteaux, C., and Lazdunski, M. (1997) J. Biol. Chem. 272, 20975-20978[Abstract/Free Full Text]
32. Babinski, K., Le, K. T., and Seguela, P. (1999) J. Neurochem. 72, 51-57[CrossRef][Medline] [Order article via Infotrieve]
33. Ishibashi, K., and Marumo, F. (1998) Biochem. Biophys. Res. Commun. 245, 589-593[CrossRef][Medline] [Order article via Infotrieve]
34. Grunder, S., Geissler, H. S., Bassler, E. L., and Ruppersberg, J. P. (2000) Neuroreport 11, 1607-1611[Medline] [Order article via Infotrieve]
35. Akopian, A. N., Chen, C. C., Ding, Y., Cesare, P., and Wood, J. N. (2000) Neuroreport 11, 2217-2222[Medline] [Order article via Infotrieve]
36. Mulberg, A. E., Wiedner, E. B., Bao, X., Marshall, J., Jefferson, D. M., and Altschuler, S. M. (1994) Neuroreport 5, 1684-1688[CrossRef][Medline] [Order article via Infotrieve]
37. Mulberg, A. E., Resta, L. P., Wiedner, E. B., Altschuler, S. M., Jefferson, D. M., and Broussard, D. L. (1995) J. Clin. Invest. 96, 646-652
38. Johannesson, M., Bogdanovic, N., Nordqvist, A. C., Hjelte, L., and Schalling, M. (1997) Neuroreport 8, 535-539[Medline] [Order article via Infotrieve]
39. Xu, Z., Gupta, V., Lei, D., Holmes, A., Carlson, E., and Gruenert, D. C. (1998) Gene (Amst.) 211, 117-123[CrossRef][Medline] [Order article via Infotrieve]
40. Ueno, S., Nakaya, T., and Akaike, N. (1992) J. Physiol. 447, 309-327[Abstract/Free Full Text]
41. Mulberg, A. E., Weyler, R. T., Altschuler, S. M., and Hyde, T. M. (1998) Neuroreport 9, 141-144[Medline] [Order article via Infotrieve]
42. Weyler, R. T., Yurko-Mauro, K. A., Rubenstein, R., Kollen, W. J., Reenstra, W., Altschuler, S. M., Egan, M., and Mulberg, A. E. (1999) Am. J. Physiol. 277, C563-C571[Abstract/Free Full Text]
43. Wetsel, W. C., Eraly, S. A., Whyte, D. B., and Mellon, P. L. (1993) Endocrinology 132, 2360-2370[Abstract/Free Full Text]
44. Jovov, B., Ismailov, I. I., Berdiev, B. K., Fuller, C. M., Sorscher, E. J., Dedman, J. R., Kaetzel, M. A., and Benos, D. J. (1995) J. Biol. Chem. 270, 29194-29200[Abstract/Free Full Text]
45. Demolombe, S., Baro, I., Bebok, Z., Clancy, J. P., Sorscher, E. J., Thomas-Soumarmon, A., Pavirani, A., and Escande, D. (1996) Gene Ther. 3, 685-694[Medline] [Order article via Infotrieve]
46. Ji, H.-L., Parker, S., Langloh, A. L., Fuller, C. M., and Benos, D. J. (2001) Am. J. Physiol. Cell Physiol. 281, 64-74
47. Kuruma, A., Hirayama, Y., and Hartzell, H. C. (2000) Am. J. Physiol. Cell Physiol. 279, 1401-1413
48. Escoubas, P., de Weille, J. R., Lecoq, A., Diochot, S., Waldmann, R., Champigny, G., Moinier, D., Menez, A., and Lazdunski, M. (2000) J. Biol. Chem. 275, 25116-25121[Abstract/Free Full Text]
49. de Weille, J., and Bassilana, F. (2001) Brain Res. 900, 277-281[CrossRef][Medline] [Order article via Infotrieve]
50. Prabhakar, N. R., and Overholt, J. L. (2000) Respir. Physiol. 122, 209-221[CrossRef][Medline] [Order article via Infotrieve]
51. Coscoy, S., de Weille, J. R., Lingueglia, E., and Lazdunski, M. (1999) J. Biol. Chem. 274, 10129-10132[Abstract/Free Full Text]
52. Nagel, G., Szellas, T., Riordan, J. R., Friedrich, T., and Hartung, K. (2001) EMBO Rep. 2, 249-254[CrossRef][Medline] [Order article via Infotrieve]
53. Ishikawa, T., Marunaka, Y., and Rotin, D. (1998) J. Gen. Physiol. 111, 825-846[Abstract/Free Full Text]
54. Berdiev, B. K., Mapstone, T. B., Markert, J. M., Gillespie, G. Y., Lockhart, J., Fuller, C. M., and Benos, D. J. (2001) J. Biol. Chem. 276, 38755-38761[Abstract/Free Full Text]
55. Immke, D. C., and McCleskey, E. W. (2001) Nat. Neurosci. 4, 869-870[CrossRef][Medline] [Order article via Infotrieve]
56. Reddy, M. M., Light, M. J., and Quinton, P. M. (1999) Nature 402, 301-304[CrossRef][Medline] [Order article via Infotrieve]
57. Chan, L. N., Wang, X. F., Tsang, L. L., Liu, C. Q., and Chan, H. C. (2000) Biochem. Biophys. Res. Commun. 276, 40-44[CrossRef][Medline] [Order article via Infotrieve]
58. Garty, H., and Palmer, L. G. (1997) Physiol. Rev. 77, 359-396[Abstract/Free Full Text]
59. Woolf, C. J., and Salter, M. W. (2000) Science 288, 1765-1768[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H.-L. Ji, W. Song, Z. Gao, X.-F. Su, H.-G. Nie, Y. Jiang, J.-B. Peng, Y.-X. He, Y. Liao, Y.-J. Zhou, et al.
SARS-CoV proteins decrease levels and activity of human ENaC via activation of distinct PKC isoforms
Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L372 - L383.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Su, Q. Li, K. Shrestha, E. Cormet-Boyaka, L. Chen, P. R. Smith, E. J. Sorscher, D. J. Benos, S. Matalon, and H.-L. Ji
Interregulation of Proton-gated Na+ Channel 3 and Cystic Fibrosis Transmembrane Conductance Regulator
J. Biol. Chem., December 1, 2006; 281(48): 36960 - 36968.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Donier, F. Rugiero, K. Okuse, and J. N. Wood
Annexin II Light Chain p11 Promotes Functional Expression of Acid-sensing Ion Channel ASIC1a
J. Biol. Chem., November 18, 2005; 280(46): 38666 - 38672.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. P. Price, R. J. Thompson, J. O. Eshcol, J. A. Wemmie, and C. J. Benson
Stomatin Modulates Gating of Acid-sensing Ion Channels
J. Biol. Chem., December 17, 2004; 279(51): 53886 - 53891.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-L. Ji and D. J. Benos
Degenerin Sites Mediate Proton Activation of {delta}{beta}{gamma}-Epithelial Sodium Channel
J. Biol. Chem., June 25, 2004; 279(26): 26939 - 26947.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. C. Askwith, J. A. Wemmie, M. P. Price, T. Rokhlina, and M. J. Welsh
Acid-sensing Ion Channel 2 (ASIC2) Modulates ASIC1 H+-activated Currents in Hippocampal Neurons
J. Biol. Chem., April 30, 2004; 279(18): 18296 - 18305.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Agopyan, J. Head, S. Yu, and S. A. Simon
TRPV1 receptors mediate particulate matter-induced apoptosis
Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L563 - L572.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-L. Ji, L. R. Bishop, S. J. Anderson, C. M. Fuller, and D. J. Benos
The Role of Pre-H2 Domains of {alpha}- and {delta}-Epithelial Na+ Channels in Ion Permeation, Conductance, and Amiloride Sensitivity
J. Biol. Chem., February 27, 2004; 279(9): 8428 - 8440.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R.C. Boucher
New concepts of the pathogenesis of cystic fibrosis lung disease
Eur. Respir. J., January 1, 2004; 23(1): 146 - 158.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Baron, E. Deval, M. Salinas, E. Lingueglia, N. Voilley, and M. Lazdunski
Protein Kinase C Stimulates the Acid-sensing Ion Channel ASIC2a via the PDZ Domain-containing Protein PICK1
J. Biol. Chem., December 20, 2002; 277(52): 50463 - 50468.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/10/8395    most recent
M109465200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ji, H.-L.
Right arrow Articles by Benos, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ji, H.-L.
Right arrow Articles by Benos, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement